Search

Author/Creator Zalupski, Mark M.

1. A multi‐institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer. Issue 15 (29th May 2013)

Authors:
Kim, Edward J.; Ben‐Josef, Edgar; Herman, Joseph M.; Bekaii‐Saab, Tanios; Dawson, Laura A.; Griffith, Kent A.; Francis, Isaac R.; Greenson, Joel K.; Simeone, Diane M.; Lawrence, Theodore S.; Laheru, Daniel; Wolfgang, Christopher L.; Williams, Terence; Bloomston, Mark; Moore, Malcolm J.; Wei, Alic...
Journal:
Cancer
Issue:
Volume 119:Issue 15(2013)
Page Start:
2692
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A multi‐institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer. Issue 15 (29th May 2013)

Authors:
Kim, Edward J.; Ben‐Josef, Edgar; Herman, Joseph M.; Bekaii‐Saab, Tanios; Dawson, Laura A.; Griffith, Kent A.; Francis, Isaac R.; Greenson, Joel K.; Simeone, Diane M.; Lawrence, Theodore S.; Laheru, Daniel; Wolfgang, Christopher L.; Williams, Terence; Bloomston, Mark; Moore, Malcolm J.; Wei, Alic...
Journal:
Cancer
Issue:
Volume 119:Issue 15(2013)
Page Start:
2692
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma. (March 2018)

Authors:
Cohen, Steven J.; Zalupski, Mark M.; Conkling, Paul; Nugent, Francis; Ma, Wen Wee; Modiano, Manuel; Pascual, Rolan; Lee, Fa Chyi; Wong, Lucas; Hersh, Evan
Journal:
American journal of clinical oncology
Issue:
Volume 41:Number 3(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A Phase II Study of Biweekly Cisplatin, Fixed-Dose-Rate Gemcitabine and Infusional 5-Fluorouracil in Patients With Metastatic Pancreatic and Biliary Cancers. (February 2018)

Authors:
Davis, Elizabeth J.; Griffith, Kent A.; Kim, Edward J.; Ruch, Joshua M.; McDonnell, Kevin J.; Zalupski, Mark M.
Journal:
American journal of clinical oncology
Issue:
Volume 41:Number 2(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma. Issue 13 (September 2015)

Authors:
Davis, Elizabeth J.; Chugh, Rashmi; Zhao, Lili; Lucas, David R.; Biermann, J. Sybil; Zalupski, Mark M.; Feng, Mary; Wong, Sandra L.; Jacobson, Jon; Zyczynski, Laurie; Reinke, Denise; Metko, Gino; Baker, Laurence H.; Schuetze, Scott M.
Journal:
European journal of cancer
Issue:
Volume 51:Issue 13(2015:Sep.)
Page Start:
1794
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT‐01. Issue 19 (27th July 2022)

Authors:
Sahai, Vaibhav; Griffith, Kent A.; Beg, Muhammad S.; Shaib, Walid L.; Mahalingam, Devalingam; Zhen, David B.; Deming, Dustin A.; Zalupski, Mark M.
Journal:
Cancer
Issue:
Volume 128:Issue 19(2022)
Page Start:
3523
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Carbohydrate antigen 19‐9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine‐containing chemotherapy. Issue 2 (11th July 2012)

Authors:
Bauer, Todd M.; El‐Rayes, Bassel F.; Li, Xiaobai; Hammad, Nazik; Philip, Philip A.; Shields, Anthony F.; Zalupski, Mark M.; Bekaii‐Saab, Tanios
Journal:
Cancer
Issue:
Volume 119:Issue 2(2013)
Page Start:
285
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Definitive Chemoradiation With Full-dose Gemcitabine for Unresectable Pancreatic Cancer: Efficacy of Involved-Field Radiotherapy. (October 2017)

Authors:
Zhou, Jessica; Fang, Charles X.; Shen, Jincheng; Schipper, Matthew J.; Zalupski, Mark M.; Minter, Rebecca M.; Simeone, Diane M.; Hart, Deanna; Eagle, Taylor; Kimmel, Grace W.; Vainshtein, Jeffrey; Lawrence, Theodore S.; Feng, Mary
Journal:
American journal of clinical oncology
Issue:
Volume 40:Number 5(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma. Issue 1 (21st November 2013)

Authors:
Welling, Theodore H.; Feng, Mary; Wan, Shanshan; Hwang, Sin Ye; Volk, Michael L.; Lawrence, Theodore S.; Zalupski, Mark M.; Sonnenday, Christopher J.
Journal:
Liver transplantation
Issue:
Volume 20:Issue 1(2014:Jan.)
Page Start:
81
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma. Issue 1 (21st November 2013)

Authors:
Welling, Theodore H.; Feng, Mary; Wan, Shanshan; Hwang, Sin Ye; Volk, Michael L.; Lawrence, Theodore S.; Zalupski, Mark M.; Sonnenday, Christopher J.
Journal:
Liver transplantation
Issue:
Volume 20:Issue 1(2014:Jan.)
Page Start:
81
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗